M&A Deal Summary |
|
|---|---|
| Date | 2019-04-30 |
| Target | GenePOC - State-of-the-Art Molecular Diagnostics Platform |
| Sector | Life Science |
| Buyer(s) | Meridian Bioscience |
| Sellers(s) | GenePOC |
| Deal Type | Divestiture |
| Deal Value | 120M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Life Science |
| Employees | 702 |
| Revenue | 318M USD (2021) |
Meridian is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Meridian was founded in 1976 and is based in Cincinnati, Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 11 |
| Sector (Life Science) | 3 of 5 |
| Type (Divestiture) | 3 of 4 |
| State (Quebec) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2019) | 1 of 1 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-24 |
Magellan Biosciences
Chelmsford, Massachusetts, United States Magellan Biosciences, Inc. is a developer and manufacturer of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-19 |
Exalenz Bioscience
Modiin, Israel Exalenz Bioscience, Inc. develops and markets diagnostic tests and monitoring systems that use the breath to diagnose and help manage gastrointestinal and liver conditions. Exalenz ’s flagship BreathID® Hp Systems offer the most efficient and accurate test for detection of H. pylori bacteria, associated with various illnesses including gastric cancer, and is already in use in over 400 U.S. medical centers and major labs across the country. Exalenz holds regulatory approvals in the United States, Europe, China, and Israel for H. pylori detection and is currently evaluating additional applications of the BreathID platform. |
Buy | $49M |
GenePOC, Inc. is a developer of accurate and cost-effective molecular solutions to detect pathogen genes. GenePOC, Inc. was founded in 2007 and is based in Québec, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Quebec) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2019) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
